A certificate of analysis is only as trustworthy as the lab that issued it. When that lab sits inside the same company selling the product, an obvious conflict of interest enters the picture. This article explains why independent third-party testing has become a baseline expectation in research peptide work.
The Conflict of Interest Problem
In-house COAs are common across the industry. They are also cheaper and faster than sending samples to an outside lab. But the financial incentive to report favorable results is built into the arrangement.
An internal QC manager who flags a bad lot can cost the company tens of thousands of dollars. An external lab has no such incentive — its reputation depends on accuracy across many clients. That structural difference is why pharmaceutical regulators rely heavily on third-party verification.
Independent testing does not assume bad faith. It simply removes the temptation entirely.
What Third-Party Labs Actually Test
A thorough independent COA covers several distinct measurements. Mass spectrometry confirms the molecular weight matches the claimed sequence. High-performance liquid chromatography (HPLC) measures purity by separating the target peptide from synthesis byproducts and degradation fragments.
Endotoxin testing checks for bacterial contamination from the manufacturing process. Net peptide content — the actual peptide mass minus salts and counterions — is a separate measurement that researchers often confuse with HPLC purity. Both numbers matter.
Some labs also run residual solvent analysis and bioburden testing. The depth of testing varies, so researchers should look at exactly which tests appear on the reported COA, not just the headline purity number.
Recognizing Trustworthy Independent Labs
Janoshik Analytical has become a frequently cited third-party lab in the research peptide space. Its reports include traceable sample IDs, raw chromatograms, and methodology notes that allow another lab to verify the work. That transparency is the hallmark of a credible report.
Other reputable labs operate similarly — they publish their methods, list accreditations such as ISO 17025, and provide raw data alongside summary numbers. A one-line "99% pure" statement on company letterhead does not meet that bar.
Researchers can also cross-reference COA serial numbers directly with the testing lab when authenticity is in question.
Why It Affects Reproducibility
A study run on a 95% pure peptide is fundamentally different from one run on an 85% pure peptide, even if the labels look identical. The 5–15% of impurities can include truncated sequences, oxidized variants, and synthesis byproducts that have their own biological activity.
Independent verification is what allows results from different labs to be compared meaningfully. Without it, replication failures can be blamed on the peptide rather than the experimental design.
Best practices around peptide quality assurance continue to evolve as analytical methods improve and new contaminants are discovered. All peptides discussed are intended strictly for research use only and are not for human consumption.